References

Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

10.1016/j.annonc.2020.06.022 · 2020 · External reference

Treatment and prognosis of early multiple gastric cancer

10.1016/s0748-7983(03)00094-5 · 2003 · External reference

Hazard rates of recurrence for gastric cancer after curative resection: implications for postoperative surveillance

10.1007/s10120-024-01576-5 · 2025 · External reference

Follow-up and strategies after curative surgical resection for gastric cancer, Korean J. Helicobacter up. Gastrointest

2025 · External reference

Toxicities and quality of life during cancer treatment in advanced solid tumors

10.3390/curroncol30100665 · 2023 · External reference

Hydrogels as local depots for on-demand therapeutic delivery: potential therapeutic approaches for tumor metastasis

10.1039/d4ma00122b · 2024 · External reference

Bioinspired long-acting mucoadhesive gastric patch for levothyroxine delivery

10.1021/acsami.4c20569 · 2025 · External reference

Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer

2025 · External reference

Built-in active microneedle patch with enhanced autonomous drug delivery

10.1002/adma.201905740 · 2020 · External reference

Green algae as a drug delivery system for the controlled release of antibiotics

10.1002/chem.202003821 · 2020 · External reference

Layer-by-layer coated probiotics with chitosan and liposomes demonstrate improved stability and antioxidant properties in vitro

10.1016/j.ijbiomac.2023.128826 · 2024 · External reference

Nanoscale bacteria-enabled autonomous drug delivery system (NanoBEADS) enhances intratumoral transport of nanomedicine

10.1002/advs.201801309 · 2019 · External reference

Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery

2022 · External reference

Engineered bacteria-nano hybrid system: the intelligent drug factory for next-generation cancer immunotherapy

10.3390/pharmaceutics17101349 · 2025 · External reference

Engineering advanced bacterial therapy for tumor and inflammatory diseases

10.1016/j.ijpharm.2025.125585 · 2025 · External reference

The synthesis, structural characterization, and receptor specificity of the α-conotoxin Vc1.1

10.1074/jbc.m604550200 · 2006 · External reference

Molecular determinants of the selectivity and potency of α-conotoxin Vc1.1 for human nicotinic acetylcholine receptors

10.1016/j.jbc.2024.108017 · 2025 · External reference

Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor

10.1021/jm400041h · 2013 · External reference

α9-containing nicotinic receptors in cancer

10.3389/fncel.2021.805123 · 2022 · External reference

Differential expression of nicotine acetylcholine receptors associates with human breast cancer and mediates antitumor activity of αO-conotoxin GeXIVA

10.3390/md18010061 · 2020 · External reference

A platform for controlled dual-drug delivery to the retina: protective effects against light-induced retinal damage in rats

10.1002/adhm.201400114 · 2014 · External reference

A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye

10.1016/j.actbio.2013.11.004 · 2014 · External reference

Manipulations in hydrogel degradation behavior enhance osteoblast function and mineralized tissue formation

10.1089/ten.2006.12.1663 · 2006 · External reference

On-site determination of water toxicity based on freeze-dried electrochemically active bacteria

10.1016/j.scitotenv.2023.161432 · 2023 · External reference

Alginate as a promising biopolymer in drug delivery and wound healing: a review of the state-of-the-art

10.3390/ijms23169035 · 2022 · External reference

An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment

10.3390/cancers14122868 · 2022 · External reference

Tumor stroma content regulates penetration and efficacy of tumor-targeting bacteria

2024 · External reference

Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis

10.1128/iai.60.10.3994-4002.1992 · 1992 · External reference

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

10.1073/pnas.120163297 · 2000 · External reference

λ-Red genetic engineering in Salmonella enterica serovar Typhimurium

10.1016/s0076-6879(06)21016-4 · 2007 · External reference

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

10.1128/jb.177.14.4121-4130.1995 · 1995 · External reference

Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo

10.1111/j.1462-5822.2007.00890.x · 2007 · External reference

Active delivery of multi-layer drug-loaded microneedle patches using magnetically driven capsule

10.1016/j.medengphy.2020.09.012 · 2020 · External reference

Migration of chemotactic bacteria in soft agar: role of gel concentration

10.1016/j.bpj.2011.06.023 · 2011 · External reference

Chitosan oral patches inspired by mussel adhesion

10.1016/j.jconrel.2019.11.006 · 2020 · External reference

Multiple sampling capsule robot for studying gut microbiome

10.1002/aisy.202300625 · 2025 · External reference

Targeted drug delivery using self-unrolling sheets in magnetically actuated capsules

10.1016/j.device.2024.100654 · 2025 · External reference

A self-deploying drug release device using polymeric films

10.1002/jbm.b.33887 · 2018 · External reference

Bacteria-elicited specific thrombosis utilizing acid-induced cytolysin A expression to enable potent tumor therapy

10.1002/advs.202105086 · 2022 · External reference

Bacterial expression of promelittin for safe and effective tumor therapy

10.1021/acsami.3c11457 · 2023 · External reference

AraC-DNA looping: orientation and distance-dependent loop breaking by the cyclic AMP receptor protein

10.1016/0022-2836(91)90872-4 · 1991 · External reference

Excretion of the anti-sigma factor through a flagellar substructure couples flagellar gene expression with flagellar assembly in Salmonella typhimurium

10.1007/bf00279569 · 1994 · External reference

Selective purification of recombinant neuroactive peptides using the flagellar type III secretion system

10.1128/mbio.00115-12 · 2012 · External reference

Tumour-specific delivery of ω- conotoxin MVIIA via engineered Salmonella for safe anticancer therapy

2025 · External reference

Engineered Salmonella delivering the NMDAR antagonist conantokin G synergizes with PD-L1 blockade to enhance colorectal cancer regression

10.1186/s40164-026-00794-0 · 2026 · External reference

Alginate-based biomaterials for regenerative medicine applications

10.3390/ma6041285 · 2013 · External reference

Skim milk powder used as a non-permeable cryoprotectant reduces oxidative and DNA damage in cryopreserved zebrafish sperm

10.1016/j.cryobiol.2020.10.005 · 2020 · External reference

CRP improves the survival and competitive fitness of Salmonella Typhimurium under starvation by controlling the cellular maintenance rate

10.1128/jb.00010-24 · 2024 · External reference

Salmonella-induced cell death in cancer immunotherapy: what lies beneath?

10.3390/biomedicines14010012 · 2025 · External reference

Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes

10.1007/s13300-019-0590-x · 2019 · External reference

Understanding treatment adherence in chronic diseases: challenges, consequences, and strategies for improvement

10.3390/jcm14176034 · 2025 · External reference

Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives

2025 · External reference

The effects of l-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans

10.3945/ajcn.111.014225 · 2011 · External reference

A mixed diet supplemented with l-arabinose does not alter glycaemic or insulinaemic responses in healthy human subjects

10.1017/s0007114514003407 · 2015 · External reference

Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors

10.1038/s41598-021-85372-6 · 2021 · External reference

Improved yield of recombinant protein via flagella regulator deletion in Escherichia coli

10.3389/fmicb.2021.655072 · 2021 · External reference

“Metabolic burden” explained: stress symptoms and its related responses induced by (over)expression of (heterologous) proteins in Escherichia coli

10.1186/s12934-024-02370-9 · 2024 · External reference

Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

10.1038/s41467-024-44776-4 · 2024 · External reference